NCT04487535

Brief Summary

Serum cytokines was assosiated with symptoms and progression of osteoartritis. It is unknown whether these cytokines have a predictive role on severity of symptoms after total knee arthroplasty (TKA) or not. The aim of this study is to investigate the relationships between the preoperative serum cytokine level (SCL) and lenght of stay in hospital, postoperative pain intensity, functional status, joint position sense and X ray. Grade 4 osteoartritis degeneration who intern the hospital for total knee arthroplasty surgery. Serum Cytokine Levels (IL-6, TNFα, IL-1β) will be assessed before surgery. Pain intensity at rest/activity and valgite angle will be evaluated before surgery, postoperative 72 hour and postoperative 6 weeks. Functional status and joint position sense will be assessed before surgery and 6 weeks after surgery. Lenght of stay in hospital (LOS) will be recorded.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
29

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2018

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2020

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2020

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

July 16, 2020

Completed
11 days until next milestone

First Posted

Study publicly available on registry

July 27, 2020

Completed
Last Updated

July 27, 2020

Status Verified

January 1, 2018

Enrollment Period

1.1 years

First QC Date

July 16, 2020

Last Update Submit

July 22, 2020

Conditions

Keywords

Total knee arthroplastyCytokinesProprioceptionPainFunctional StatusLenght of Stay in hospital

Outcome Measures

Primary Outcomes (1)

  • Pain intensty

    Rest and activity pain intensity will be evaluated by using 100 mm vertical line Visual Anolog Scale (VAS). Zero meet no pain, 10 unbearable pain

    pain intensity will be evaluated. It will determined pain intensity alteration from 2 weeks before surgery and at 72 hours and at 6 weeks following surgery

Secondary Outcomes (4)

  • Functional Status

    Functional status will be assessed before surgery and 6 weeks after surgery

  • Joint Position Sense

    It will be evaluated before surgery and 6 weeks after surgery

  • X-Ray

    X-ray evaluated before surgery, 72 hour after surgery and 6 weeks ater surgery

  • Serum Cytokine Level

    Venous blood sample was collected 2 weeks before surgery

Study Arms (1)

Standard Total Knee Arthroplasty Surgery

OTHER

Surgery performed by one orthopedic surgeon

Other: Cytokine level

Interventions

Serum cytokine level will be measured before surgery, 72nd after surgery and 6 weeks after surgery

Standard Total Knee Arthroplasty Surgery

Eligibility Criteria

Age45 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • aged between 45-75
  • were scheduled for unilateral or bilateral TKA
  • were diagnosed of OA with a severity Grade 4 according to the Kellgren-Lawrence (KL) classification.

You may not qualify if:

  • neuropathic pain
  • presurgery for same lower extremity
  • vascular disease
  • any chronic disease related to kidney, heart, liver
  • cancer
  • chronic inflammatory disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hacettepe Universty

Ankara, Sıhhıye, 06100, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Pain

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Karadeniz Technical University

Study Record Dates

First Submitted

July 16, 2020

First Posted

July 27, 2020

Study Start

December 1, 2018

Primary Completion

January 1, 2020

Study Completion

February 1, 2020

Last Updated

July 27, 2020

Record last verified: 2018-01

Data Sharing

IPD Sharing
Will not share

Locations